Sreten Franovic

Sreten Franovic

Auto-generated profile, based on publicly available information

Sreten Franovic

Department of Orthopedic Surgery, Henry Ford Health System, Detroit, MI, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in JBJS Open Access
Verified
Journal Article
Open access
SFSreten Franovic
Sreten Franovic
CGCaleb M. Gulledge
Caleb M. Gulledge
NKNoah A. Kuhlmann
Noah A. Kuhlmann
TWTyler H. Williford
Tyler H. Williford
Chaoyang ChenChaoyang Chen
Chaoyang Chen
EMEric C. Makhni
Eric C. Makhni
Background: Numerous recent studies have demonstrated the validity and efficiency of the National Institutes of Health Patient-Reported Outcomes Measurement Information System (PROMIS) forms in patients undergoing orthopaedic surgical procedures. It is assumed that a score of 50 in each domain represents the health state of a “reference” population, but this threshold has not been definitively proven. In order to truly assess whether a given orthopaedic intervention is successful, the comparative scores of healthy individuals must be known for any given health domain measured. Therefore, the purpose of this study was to determine baseline scores for the PROMIS general physical function (PROMIS-PF), pain interference (PROMIS-PI), and upper-extremity physical function (PROMIS-UE) domains in physically healthy, asymptomatic adult individuals. We hypothesized that, in individuals 50 and PROMIS-PI scores would be <50. We further hypothesized that these scores would be impacted by participant age. Methods: Three PROMIS computer adaptive test (CAT) domains were administered (either in person or through email) to healthy adult volunteers. These domains included PROMIS-PF, PROMIS-UE, and PROMIS-PI. Individuals who reported joint pain or dysfunction were excluded. Results: In total, 294 healthy volunteers with a mean age of 33.2 years (range, 18 to 83 years) completed all 3 PROMIS CAT forms. The mean (and standard deviation) PROMIS-UE, PROMIS-PF, and PROMIS-PI scores were 55.9 ± 6.6, 59.7 ± 8.0, and 43.6 ± 7.6, respectively, for individuals <40 years old and 51.2 ± 8.2, 52.9 ± 7.6, and 49.0 ± 8.0, respectively, for individuals ≥40 years old. Age correlated significantly with PROMIS-UE and PROMIS-PF in the older cohort. Conclusions: For individuals <40 years old, baseline PROMIS-PF scores were significantly higher than 50 and PROMIS-PI scores were significantly lower. This difference was less pronounced in individuals ≥40 years old. When treating young patients, clinicians should be cognizant of these healthy baseline scores. Clinical Relevance: In this study, reference range for asymptomatic musculoskeletal volunteers was determined across PROMIS CAT forms. These reference scores are important in treating and counseling patients with musculoskeletal conditions in order to determine relative impairment or functional capabilities.

31 May 2021 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
BDBrian Darrith
Brian Darrith
LKLafi S. Khalil
Lafi S. Khalil
SFSreten Franovic
Sreten Franovic
MBMichael Bazydlo
Michael Bazydlo
RWRobb M. Weir
Robb M. Weir
JDJason J. Davis
Jason J. Davis
Introduction: The patient-specific factors influencing postoperative improvement after total knee arthroplasty (TKA) are important considerations for the surgeon and patient. The primary purpose of this study was to determine which patient demographic factors influence the postoperative Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health (GH) scores. In addition, we aimed to compare the prognostic utility of preoperative PROMIS-GH scores and the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) in predicting postoperative improvement. Methods: This retrospective cohort study of a consecutive series of patients who underwent primary, unilateral TKA analyzed prospectively collected KOOS-JR and PROMIS-GH surveys. PROMIS-GH includes physical health (PH) and mental health scores. Patient demographic and presurgical characteristics were evaluated for prognostic capability in predicting postoperative improvement in the PROMIS scores and achievement of the minimal clinically important difference (MCID). Receiver operating characteristic curves were used to understand the prognostic thresholds of the preoperative PROMIS score and KOOS-JR for predicting MCID achievement. Results: A total of 872 patients were included. Although unadjusted analyses showed associations between patient demographic factors and PROMIS-PH scores, multivariable regression analysis for predictors of MCID achievement demonstrated that PROMIS-PH was the only significant preoperative variable. Receiver operating characteristic analysis revealed that the area under the curve of PROMIS-PH (0.70; 95% CI, 0.67 to 0.74) was less than that of the KOOS-JR (0.77; 95% CI, 0.73 to 0.81; P = 0.032). Sensitivity and specificity for achieving the MCID were maximized for preoperative PROMIS-PH scores of ≤ 38 (59% and 70%) and for preoperative KOOS-JR ≤ 51 (71% and 69%). Conclusions: Preoperative KOOS-JR and PROMIS-PH scores predict clinically meaningful improvement after TKA. The KOOS-JR has greater prognostic utility in the early postoperative period. Level of Evidence: Level III, Prognostic Study

13 February 2022 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
JTJoseph S. Tramer
Joseph S. Tramer
NYNikhil R. Yedulla
Nikhil R. Yedulla
AZAlexander C. Ziedas
Alexander C. Ziedas
MPMit Patel
Mit Patel
SFSreten Franovic
Sreten Franovic
EMEric C. Makhni
Eric C. Makhni

1 July 2021 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
EKElizabeth A. Klag
Elizabeth A. Klag
NKNoah A. Kuhlmann
Noah A. Kuhlmann
JTJoseph S. Tramer
Joseph S. Tramer
SFSreten Franovic
Sreten Franovic
SMStephanie J. Muh
Stephanie J. Muh

6 May 2019 in Arthroscopy Techniques
Verified
Journal Article
Open access
VLVincent A. Lizzio
Vincent A. Lizzio
CGCaleb M. Gulledge
Caleb M. Gulledge
FMFabien Meta
Fabien Meta
SFSreten Franovic
Sreten Franovic
EMEric C. Makhni
Eric C. Makhni
Modern health care places significant emphasis on patient‐centered care. As a result, many orthopaedic providers are incorporating routine patient‐reported outcome measure (PROM) collection into their practice. However, routine PROM collection often disrupts clinical workflow and can place a burden on both the patient and the provider. Electronic PROM collection systems, if implemented deliberately to maximize convenience and efficiency, have the potential to mitigate these obstacles. This technique guide presents an overview of designing and implementing a PROM‐based clinical registry for the ambulatory orthopaedic clinic using Research Electronic Data Capture (REDCap; Vanderbilt University, Nashville, TN). We outline the basic steps of creating a simple but effective patient registry using this accessible data collection platform. Technique Video: video See video under supplementary data.

1 April 2021 in JBJS Open Access
Verified
Journal Article
Open access
SFSreten Franovic
Sreten Franovic
APAlex Pietroski
Alex Pietroski
NKNoah Kuhlmann
Noah Kuhlmann
TBTalal Bazzi
Talal Bazzi
YZYang Zhou
Yang Zhou
SMStephanie Muh
Stephanie Muh
Background: The treatment of Rockwood Grade-III acromioclavicular (AC) joint separation has been widely disputed since the introduction of the classification system. The present literature does not reach consensus on whether operative or nonoperative management is more advantageous, nor does it effectively distinguish between operative measures. We hypothesized that nonoperative treatment of Rockwood Grade-III AC joint separation would be more cost-effective when compared with surgical options. Methods: We created a decision-tree model outlining the treatment of Rockwood Grade-III separations using nonoperative management or hook-plate, suture-button, or allograft fixation. After nonoperative intervention, the possible outcomes predicted by the model were uneventful healing, delayed operative management, a second round of sling use and physical therapy, or no reduction and no action; and after operative intervention, the possible outcomes were uneventful healing, loss of reduction and revision, and depending on the implant, loss of reduction and no action, or removal of the implant. A systematic review was conducted, and probabilities of each model state were averaged. A cost-effectiveness analysis was conducted both through rollback analysis yielding net monetary benefit and through incremental cost-effectiveness ratios (ICERs). Thresholds of $50,000/quality-adjusted life-year (QALY) and $100,000/QALY were used for ICER analysis. Furthermore, a sensitivity analysis was utilized to determine whether differential probabilities could impact the model. Results: Forty-five papers were selected from a potential 768 papers identified through our literature review. Nonoperative treatment was used as our reference case and showed dominance over all 3 of the operative measures at both the $50,000 and $100,000 ICER thresholds. Nonoperative treatment also showed the greatest net monetary benefit. Nonoperative management yielded the lowest total cost ($6,060) and greatest utility (0.95 QALY). Sensitivity analysis showed that allograft fixation became the favored technique at a willingness-to-pay threshold of $50,000 if the rate of failure of nonoperative treatment rose to 14.6%. Similarly, at the $100,000 threshold, allograft became dominant if the probability of failure of nonoperative treatment rose to 22.8%. Conclusions: The cost-effectiveness of nonoperative treatment is fueled by its notably lower costs and overall high rates of success in Grade-III separations. It is important to note that, in our analysis, the societal cost (measured in lost productivity) of nonoperative treatment neared that of surgical treatment, but the cost from the health-care system perspective was minimal. Physicians should bear in mind the sensitivity of these conclusions and should consider cost-effectiveness analyses in their decision-making guidelines. Level of Evidence: Economic and Decision Analysis Level IV. See Instructions for Authors for a complete description of levels of evidence.